Nasal spray steroid formulation and method
US7029657B2 · kind B2 · utility
7Cited by
18References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2002 |
| Grant date | Apr 18, 2006 |
| Priority date | — |
| Expiry date | May 10, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/724
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an improvement in a method of contraception, in treatment of benign gynecological disorders, and in hormone replacement. The improved method includes administering intranasally an estrogenic compound and an androgenic compound, and in some embodiments an optional progestin compound, in a once-daily bolus formulation comprised of the two or three steroids complexed with a cyclodextrin. An intranasal delivery system for administration of the formulation is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.